Medical News

RSS

Ensign board declares quarterly cash dividend

The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before January 31, 2011 to shareholders of record as of December 31, 2010.

16 Dec 2010

Envoy's successfull application of bacTRAP technology triggers milestone payment from Merck

Envoy Therapeutics, a drug discovery company, today announced that it has reached a milestone in its strategic alliance with Merck.

16 Dec 2010

New visualisation software tool for older people to understand mobility problems

Mobility challenges facing older people can now be better understood by clinicians, healthcare practitioners and design professionals, thanks to a new innovative software tool.

16 Dec 2010

UT Southwestern and Rabin Medical Center enter innovative 5-year affiliation agreement

UT Southwestern Medical Center and Rabin Medical Center, Israel, two of the world's top academic medical centers, announced today that they have entered into an innovative affiliation agreement for the next five years.

16 Dec 2010

Harmful ingredients in toxic toys need to banned

Manufacturer recalls of toys, promotional drinking glasses, and other children's products constitute an ongoing "toxic toys crisis" that requires banning potentially harmful ingredients in these products and other changes in policy and practices. That's the conclusion of a new analysis in ACS' journal Environmental Science & Technology.

16 Dec 2010

Three million Western Europeans suffer from critical limb ischemia

A recent analysis published by THE SAGE GROUP concluded that 3 million people in Western Europe have critical limb ischemia (CLI). Reflecting the aging population, this number is projected to grow to 4 million by 2030.

16 Dec 2010

Precise method to measure telomeres

Life Length, S.L. is a new biotechnology company set up to measure the length of telomeres which form caps at the end of chromosomes and that have a fundamental role in avoiding the break down and the aging of cells and organisms. The breakthroughs that Dr. Maria Blasco has made at the Spanish National Cancer Research Centre (Centro Nacional de Investigaciones Oncologicas, or CNIO) in Madrid, Spain form the founding basis of the company.

16 Dec 2010

Study reports protective shield fluoride on teeth is 100 times thinner

In a study that the authors describe as lending credence to the idiom, "by the skin of your teeth," scientists are reporting that the protective shield fluoride forms on teeth is up to 100 times thinner than previously believed.

16 Dec 2010

Perirhinal cortex critical for forming unconscious conceptual memories

A small area deep in the brain called the perirhinal cortex is critical for forming unconscious conceptual memories, researchers at the UC Davis Center for Mind and Brain have found.

16 Dec 2010

Zenobia, Lundbeck enter research collaboration for LRRK2 Parkinson's disease target

Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.

16 Dec 2010

BioAlliance wins grant and award for new applications of mucoadhesive Lauriad technology

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, announces the award of a grant from the ANR (the French state Research National Agency) and a label award from both "Clusters of excellence", Medicen Paris Region and Atlanpole, for two new applications of its mucoadhesive Lauriad™ technology. These projects are dedicated to the development of new biological products based on the Lauriad™ technology allowing mucous penetration of a biologically active compound.

16 Dec 2010

AMA commends President Obama for commitment to one-year delay of Medicare cut into law

"Today, President Obama signed into law a one-year delay of the looming Medicare physician payment cut that would have hurt seniors' health care. The AMA commends President Obama and bipartisan leaders in the Senate and House for their commitment to a year-long delay of the 25 percent cut. The AMA strongly advocated for this one-year delay to create a stable environment for seniors and their physicians.

16 Dec 2010

Fabric softener sheets repel fungus gnat adults under laboratory conditions

For years, gardeners have claimed that putting Bounce- fabric softener sheets in their pockets is an effective way to repel pests like mosquitoes and gnats.

16 Dec 2010

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.

16 Dec 2010

IDS recieves grant for two CLTM systems

Imaging Diagnostic Systems, Inc., a pioneer in laser breast imaging, announced today that it has received deposits for two CTLM systems from its distributor Mukesh Jain of Jainsons Pty Ltd for India and Indonesia.

16 Dec 2010

BELLUS Health, Celtic Therapeutics initiate KIACTA global confirmatory phase III clinical study for AA amyloidosis

BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.

16 Dec 2010

IPS examines NGOs' call to reform World Bank's funding for poorest countries

"With the World Bank expected to announce a new funding package for the world's poorest countries Wednesday, NGOs are making a last-minute appeal to donor countries to use their leverage to compel reforms at the institution," Inter Press Service reports in an article examining the changes being requested and considered.

16 Dec 2010

Study: People who believe in justice believe that tragedy gives the victim's life more meaning

Seeing bad things happen to other people is scary. One way to respond to this is to blame the victim-to look for some reason why it happened to them. But there's another common response, according to a new study published in Psychological Science, a journal of the Association for Psychological Science. The researchers found that people who believe in justice in the world also believe that a tragedy gives the victim's life more meaning.

16 Dec 2010

ADA supports FDA panel's recommendation for continuing review of existing, new scientific information

The American Dental Association today praised a Food and Drug Administration advisory panel's finding that the FDA acted appropriately when it ruled last year that dental amalgam is a safe and effective treatment option for the general population.

16 Dec 2010

EBRI report: Young people, minorities, and low-wage workers more likely to find financial incentives extremely useful

The overall percentage of people who think getting a financial incentive would be extremely or very useful for choosing a more effective treatment decreased from 61 percent in 2009 to 55 percent in 2010, according to new report released today by the nonpartisan Employee Benefit Research Institute (EBRI).

16 Dec 2010

Medical News

Ensign board declares quarterly cash dividend

Envoy's successfull application of bacTRAP technology triggers milestone payment from Merck

New visualisation software tool for older people to understand mobility problems

UT Southwestern and Rabin Medical Center enter innovative 5-year affiliation agreement

Harmful ingredients in toxic toys need to banned

Three million Western Europeans suffer from critical limb ischemia

Precise method to measure telomeres

Study reports protective shield fluoride on teeth is 100 times thinner

Perirhinal cortex critical for forming unconscious conceptual memories

Zenobia, Lundbeck enter research collaboration for LRRK2 Parkinson's disease target

BioAlliance wins grant and award for new applications of mucoadhesive Lauriad technology

AMA commends President Obama for commitment to one-year delay of Medicare cut into law

Fabric softener sheets repel fungus gnat adults under laboratory conditions

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

IDS recieves grant for two CLTM systems

BELLUS Health, Celtic Therapeutics initiate KIACTA global confirmatory phase III clinical study for AA amyloidosis

IPS examines NGOs' call to reform World Bank's funding for poorest countries

Study: People who believe in justice believe that tragedy gives the victim's life more meaning

ADA supports FDA panel's recommendation for continuing review of existing, new scientific information

EBRI report: Young people, minorities, and low-wage workers more likely to find financial incentives extremely useful

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News